tradingkey.logo
tradingkey.logo
Search

Mangoceuticals Inc

MGRX
Add to Watchlist
0.440USD
+0.028+6.85%
Market hours ETQuotes delayed by 15 min
6.11MMarket Cap
LossP/E TTM

Mangoceuticals Inc

0.440
+0.028+6.85%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+6.85%

5 Days

+20.55%

1 Month

+38.89%

6 Months

-29.60%

Year to Date

-40.54%

1 Year

-73.49%

Key Figures
0.424Open
0.447High
50.10KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.36%Turnover Ratio
0.412Prev. Close
0.410Low
13.62KTurnover
LossP/E Static
0.39P/B
0.00%Div Yield TTM
-106.11%ROA
2.87552wk High
0.54Volume Ratio
-8.71MNet Profit
13.88MShares
-1.3192EPS TTM
--Beta
-120.87%ROE
0.16252wk Low
8.91%Amplitude
-365.16%Gross Margin
6.11MMarket Cap
3.05Reward/Risk
9.83%Risk Rate

TradingKey Stock Score of Mangoceuticals Inc

Currency: USD Updated: 2026-07-17

Key Insights

Mangoceuticals Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 63 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Mangoceuticals Inc's Score

Industry at a Glance

Industry Ranking
63 / 75
Overall Ranking
364 / 4556
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Mangoceuticals Inc Highlights

StrengthsRisks
Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Growing
The company is in a growing phase, with the latest annual income totaling USD 456.02K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 456.02K.
Overvalued
The company’s latest PE is -0.31, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.67M shares, increasing 44.53% quarter-over-quarter.

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space

Mangoceuticals Inc News

More news coming soon, stay tuned...

Earnings Forecast

No Data

Indicators

Indicators
Sell(1)
Neutral(2)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.005
Buy
RSI(14)
55.015
Neutral
STOCH(KDJ)(9,3,3)
52.551
Buy
ATR(14)
0.045
High Vlolatility
CCI(14)
65.033
Neutral
Williams %R
44.769
Buy
TRIX(12,20)
0.121
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
0.385
Buy
MA10
0.384
Buy
MA20
0.377
Buy
MA50
0.388
Buy
MA100
0.389
Buy
MA200
0.819
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Mangoceuticals Inc Info

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Ticker SymbolMGRX
CompanyMangoceuticals Inc
CEOCohen (Jacob D)
Websitehttps://www.mangorx.com/

Shareholders

Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.05%
Cohen (Jacob D.)
7.75%
Ikarian Capital LLC
0.81%
Myers (Kenny)
0.81%
D'Alessio (Lorraine Pamela)
0.81%
Other
80.77%

FAQs

What is the current price of Mangoceuticals Inc (MGRX)?

The current price of Mangoceuticals Inc (MGRX) is 0.41.

What is the symbol of Mangoceuticals Inc?

The ticker symbol of Mangoceuticals Inc is MGRX.

What is the 52-week high of Mangoceuticals Inc?

The 52-week high of Mangoceuticals Inc is 2.88.

What is the 52-week low of Mangoceuticals Inc?

The 52-week low of Mangoceuticals Inc is 0.16.

What is the market capitalization of Mangoceuticals Inc?

The market capitalization of Mangoceuticals Inc is 7.07M.

What is the Earnings Per Share (EPS TTM) of Mangoceuticals Inc (MGRX)?

The Earnings Per Share (EPS TTM) of Mangoceuticals Inc (MGRX) is -2.17.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.